These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 9163560
1. Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys. Domino EF, Ni L, Zhang H, Kohno Y, Sasa M. Eur J Pharmacol; 1997 May 01; 325(2-3):137-44. PubMed ID: 9163560 [Abstract] [Full Text] [Related]
2. Trihexyphenidyl interactions with the dopamine D1-selective receptor agonist SKF-82958 and the D2-selective receptor agonist N-0923 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced hemiparkinsonian monkeys. Domino EF, Ni L. J Pharmacol Exp Ther; 1998 Jan 01; 284(1):307-11. PubMed ID: 9435192 [Abstract] [Full Text] [Related]
3. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys. Domino EF, Sheng J. J Pharmacol Exp Ther; 1993 Jan 01; 264(1):221-5. PubMed ID: 8093726 [Abstract] [Full Text] [Related]
11. The behavioural effects of pramipexole, a novel dopamine receptor agonist. Maj J, Rogóz Z, Skuza G, Kołodziejczyk K. Eur J Pharmacol; 1997 Apr 11; 324(1):31-7. PubMed ID: 9137910 [Abstract] [Full Text] [Related]
12. Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice. Kitamura Y, Kohno Y, Nakazawa M, Nomura Y. Jpn J Pharmacol; 1997 May 11; 74(1):51-7. PubMed ID: 9195297 [Abstract] [Full Text] [Related]
13. Selective full dopamine D1-like (SKF-82958) and D2-like (N-0923) agonist combination in the MPTP monkey model of hemiparkinsonism. Domino EF. Brain Res Bull; 1997 May 11; 43(1):93-5. PubMed ID: 9205801 [Abstract] [Full Text] [Related]
17. Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat. Nagashima M, Yamada K, Kimura H, Matsumoto S, Furukawa T. Pharmacol Biochem Behav; 1992 Dec 11; 43(4):993-7. PubMed ID: 1361996 [Abstract] [Full Text] [Related]
18. Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. Mierau J, Schingnitz G. Eur J Pharmacol; 1992 May 14; 215(2-3):161-70. PubMed ID: 1356788 [Abstract] [Full Text] [Related]
19. Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys. Akai T, Ozawa M, Yamaguchi M, Mizuta E, Kuno S. J Pharmacol Exp Ther; 1995 Apr 14; 273(1):309-14. PubMed ID: 7714782 [Abstract] [Full Text] [Related]
20. The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958. Andringa G, Lubbers L, Drukarch B, Stoof JC, Cools AR. Behav Pharmacol; 1999 Mar 14; 10(2):175-82. PubMed ID: 10780830 [Abstract] [Full Text] [Related] Page: [Next] [New Search]